Search by Drug Name or NDC

    NDC 60505-6097-00 Ibandronate Sodium 3 mg/3mL Details

    Ibandronate Sodium 3 mg/3mL

    Ibandronate Sodium is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is IBANDRONATE SODIUM.

    Product Information

    NDC 60505-6097
    Product ID 60505-6097_75ca1077-00cc-4742-debb-8340ceb3fb4f
    Associated GPIs 30042048102030
    GCN Sequence Number 060257
    GCN Sequence Number Description ibandronate sodium SYRINGE 3 MG/3 ML INTRAVEN
    HIC3 P4L
    HIC3 Description BONE RESORPTION INHIBITORS
    GCN 26368
    HICL Sequence Number 017291
    HICL Sequence Number Description IBANDRONATE SODIUM
    Brand/Generic Generic
    Proprietary Name Ibandronate Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name ibandronate sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 3
    Active Ingredient Units mg/3mL
    Substance Name IBANDRONATE SODIUM
    Labeler Name Apotex Corp.
    Pharmaceutical Class Bisphosphonate [EPC], Diphosphonates [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204222
    Listing Certified Through 2024-12-31

    Package

    NDC 60505-6097-00 (60505609700)

    NDC Package Code 60505-6097-0
    Billing NDC 60505609700
    Package 1 SYRINGE, GLASS in 1 CARTON (60505-6097-0) / 3 mL in 1 SYRINGE, GLASS
    Marketing Start Date 2016-01-13
    NDC Exclude Flag N
    Pricing Information N/A